Standout Papers

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer 2020 2026 2022 2024243
  1. Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (2020)
    Neal D. Shore, Fred Saad et al. New England Journal of Medicine

Immediate Impact

20 standout
Sub-graph 1 of 7

Citing Papers

Advances in diagnosis and treatment of bladder cancer
2024 Standout
HER2-targeted therapies in cancer: a systematic review
2024 Standout
1 intermediate paper

Works of Vicky Kang being referenced

SGNTUC-019: Phase 2 basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations (trial in progress).
2021

Author Peers

Author Last Decade Papers Cites
Vicky Kang 30 52 199 103 60 12 296
William Friedel 58 47 245 105 30 8 302
Abdulla Alhasso 16 47 122 61 35 15 193
G Kullmann 114 18 106 153 24 9 301
Brock R. Baker 24 28 133 66 45 11 222
Marjan Emami 26 55 127 47 49 11 319
Sana Qureshi 64 29 71 95 40 14 286
Arturo Mendoza-Valdés 58 27 159 49 58 9 289
Nadia Ben Lagha 54 20 79 40 54 14 263
Martine Labbé 46 25 55 74 73 10 318
Mateya Trinkaus 29 51 36 67 68 13 246

All Works

Loading papers...

Rankless by CCL
2026